Frank A. Anania
Affiliations: | 2018 | Biological and Biomedical Sciences | Emory University, Atlanta, GA |
Area:
Nutrition, Biochemistry, GeneralWebsite:
http://medicine.emory.edu/digestive-diseases/emory-first-faculty-directory/profile.html?f=FANANIAGoogle:
"Frank A. Anania"Bio:
http://www.biomed.emory.edu/academics/faculty-detail.html?action=getFacultyDetail&gdbbsId=afec527e-dd59-41b1-9c3e-2f747ae1cb4c
http://medicine.emory.edu/digestive-diseases/labs/anania-lab/
http://www.emorydailypulse.com/2018/01/22/frank-anania-leaving-emory-university/
https://www.pittmed.health.pitt.edu/aug_2003/PMED.pdf
Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rai RP, Liu Y, Iyer SS, et al. (2020) Blocking integrin αβ-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis. Journal of Hepatology |
| Noureddin M, Chan JL, Barradas K, et al. (2020) Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum. Gastroenterology |
| Gupta B, Liu Y, Chopyk DM, et al. (2020) Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology |
| Palmer M, Regev A, Lindor K, et al. (2019) Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Alimentary Pharmacology & Therapeutics |
| Chinnadurai R, Sands J, Rajan D, et al. (2019) Molecular genetic and immune functional responses distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate Cells. Stem Cells (Dayton, Ohio) |
| Regev A, Palmer M, Avigan MI, et al. (2019) Review article: consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics |
| Kumar P, Raeman R, Chopyk DM, et al. (2018) Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1864: 3537-3545 |
| Kumar P, Smith T, Raeman R, et al. (2018) Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells. The Journal of Biological Chemistry |
| Pillai AA, Anania FA, Pearlman BL. (2016) Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy. The American Journal of Gastroenterology. 111: 1854-1856 |
| Tedesco D, Thapa M, Gumber S, et al. (2016) CD4+ Foxp3+ T cells promote aberrant IgG production and maintain CD8+ T cell suppression during chronic liver disease. Hepatology (Baltimore, Md.) |